Evaluation of serum HER2-ECD levels in patients with gastric cancer

HER2-positive gastric cancer

(2013) Narikazu Boku   Gastric Cancer

Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association

(2013) Hideaki Shimada et al.   Gastric Cancer

HER2 Testing in Gastric Cancer

(2010) Luca Albarello et al.   ADVANCES IN ANATOMIC PATHOLOGY

Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial

(2010) Isabell Witzel et al.   BREAST CANCER RESEARCH AND TREATMENT

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival

(2008) V. Ludovini et al.   ANNALS OF ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY